posterguard
HomeDrug Discovery

Drug Discovery

Drug Discovery

Innovative Technologies Accelerating First-In-Human to Proof-of-Concept

Aernout van Haarst, Director, Scientific Affairs, & Sabina Paglialunga, Director, Scientific Affairs, Celerion -
During the earliest stages of clinical drug development, pharmaceutical and biotech companies need to make critical go / no-go decisions for their investigational products....
Drug Discovery

Developing Animal Free Organoid Models for Drug Discovery

Aline F. Miller, Professor of Biomolecular Engineering, The University of Manchester -
There is an increasing drive within the pharmaceutical and personal care communities to reduce, if not eliminate, the use of animals in the testing...
Drug Discovery

The Future of Neovascular Macular Degeneration Treatment

Michael W Stewart, Professor and Chairman of Ophthalmology, Mayo Clinic Alix School of Medicine -
The development of sight-saving pharmacotherapy for neovascular age-related macular degeneration (nAMD) has arguably been the most significant ophthalmologic advance of the past 20 years....
Drug Discovery

Intranasal powders – an exciting new dosage form for inhalation

Paul Shields, CEO, Enteris BioPharma, & Gemma Budd, Business Development Director, Nanopharm -
The choice of dosage form is one of the first decisions facing drug development scientists. For most drugs, the answer is simple: formulate as...
Drug Discovery

Finding a Way Through the Life-threatening Detriments of Antimicrobial Resistance

Lifescience Outlook -
The US Food and Drug Administration has officially approved AbbVie's EMBLAVEO™ (aztreonam and avibactam) as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination...
123Page 2 of 3

Hot Topics

Load more

2026 © Life Sciences Business Outlook. All rights reserved.

Quick Links

Must Read

Popular Articles